Biosimilar Launch Hospira recently launched a biosimilar version of infliximab to treat autoimmune diseases, offering a competitive alternative to existing products in the market. Targeting healthcare providers who prescribe these medications could present sales opportunities.

Infusion Technology Partnership Partnering with Smith Medical for infusion pump marketing indicates a focus on advanced healthcare technology solutions. This partnership could open doors for collaborative sales initiatives targeting hospitals and medical facilities looking for innovative equipment.

Product Launch Success The successful launch of LifeShield Supercath 5 safety I.V. Catheters showcases Hospira's commitment to product innovation and safety. Engaging with healthcare institutions prioritizing patient care and safety could lead to potential sales partnerships.

New Product Line Expansion The introduction of the VISIV line of PVC/DEHP-free IV bags demonstrates Hospira's response to sustainability trends in healthcare. Targeting healthcare facilities aiming to reduce plastic waste could present valuable sales opportunities for eco-friendly product offerings.

Quality Assurance Focus Despite recall issues, Hospira's dedication to addressing quality assurance and regulatory compliance is evident. Positioning sales pitches around reliability and adherence to safety standards can resonate well with healthcare organizations valuing product integrity.